Edition:
United Kingdom

InVivo Therapeutics Holdings Corp (NVIV.OQ)

NVIV.OQ on NASDAQ Stock Exchange Capital Market

1.60USD
16 Jan 2019
Change (% chg)

$0.00 (+0.00%)
Prev Close
$1.60
Open
$1.57
Day's High
$1.60
Day's Low
$1.56
Volume
8,096
Avg. Vol
31,838
52-wk High
$24.50
52-wk Low
$1.37

Chart for

About

InVivo Therapeutics Holdings Corp., formerly Design Source, Inc., is a research and clinical-stage biomaterials and biotechnology company. The Company is engaged in developing and commercializing biopolymer-scaffolding devices for the treatment of spinal cord injuries (SCI). The Company's approach to treating acute SCIs is based... (more)

Overall

Beta: 3.34
Market Cap(Mil.): $53.11
Shares Outstanding(Mil.): 32.18
Dividend: --
Yield (%): --

Financials

  NVIV.OQ Industry Sector
P/E (TTM): -- 195.02 34.38
EPS (TTM): -0.76 -- --
ROI: -83.17 9.63 14.96
ROE: -86.11 15.55 16.53

Earnings vs. Estimates